{
    "Trade/Device Name(s)": [
        "NOVA Lite DAPI dsDNA Crithidia luciliae Kit",
        "NOVA Lite\u00ae DAPI dsDNA Crithidia luciliae Kit"
    ],
    "Submitter Information": "Inova Diagnostics, Inc.",
    "510(k) Number": "K192916",
    "Predicate Device Reference 510(k) Number(s)": [
        "K880742"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KTL",
        "PIV"
    ],
    "Summary Letter Date": "November 11, 2020",
    "Summary Letter Received Date": "November 12, 2020",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear Antibody Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-double stranded DNA (dsDNA) IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "NOVA View Automated Fluorescence Microscope",
        "Manual fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Indirect immunofluorescent assay"
    ],
    "Methodologies": [
        "Indirect immunofluorescence",
        "Automated digital image analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for NOVA Lite DAPI dsDNA Crithidia luciliae Kit, an indirect immunofluorescent assay for anti-dsDNA IgG antibodies in serum using manual and automated fluorescence microscopy.",
    "Indications for Use Summary": "Qualitative and/or semi-quantitative determination of anti-double stranded DNA (dsDNA) IgG antibodies in human serum to aid in the diagnosis of systemic lupus erythematosus (SLE), using manual or automated fluorescence microscopy, with results confirmed by a trained operator.",
    "fda_folder": "Immunology"
}